Edition:
United States

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

44.12USD
18 Jan 2019
Change (% chg)

$1.02 (+2.37%)
Prev Close
$43.10
Open
$43.41
Day's High
$44.14
Day's Low
$42.96
Volume
1,095,795
Avg. Vol
872,587
52-wk High
$45.12
52-wk Low
$35.10

Latest Key Developments (Source: Significant Developments)

Hologic Prelim Q1 Revenue Rises About 5 Pct To $831 Mln
Monday, 7 Jan 2019 08:00am EST 

Jan 7 (Reuters) - Hologic Inc ::HOLOGIC PRELIMINARY REVENUES INCREASE APPROXIMATELY 5% TO $831 MILLION IN FIRST QUARTER OF FISCAL 2019.Q1 REVENUE $831 MILLION VERSUS REFINITIV IBES ESTIMATE OF $811.3 MILLION.  Full Article

Hologic - Refinanced Its Term Loan And Revolving Credit Facility Dated As Of October 3, 2017
Tuesday, 18 Dec 2018 06:14am EST 

Dec 18 (Reuters) - Hologic Inc ::HOLOGIC INC - REFINANCED ITS TERM LOAN AND REVOLVING CREDIT FACILITY DATED AS OF OCTOBER 3, 2017.HOLOGIC INC SAYS AMENDED CREDIT AGREEMENT INCLUDES A $1.5 BILLION SENIOR TERM LOAN AND $1.5 BILLION REVOLVING CREDIT FACILITY - SEC FILING.HOLOGIC INC SAYS AMENDED CREDIT AGREEMENT EXTENDS THE MATURITY OF FACILITIES TO DECEMBER 15, 2023.HOLOGIC INC - LENDERS CONVERTED THEIR COMMITMENTS UNDER ORIGINAL CREDIT AGREEMENT INTO NEW CREDIT FACILITIES.HOLOGIC INC - COMPANY HAS INITIALLY BORROWED $350 MILLION UNDER REVOLVER..  Full Article

Hologic Announces Q4 Revenue of $813.5 Million
Wednesday, 7 Nov 2018 04:01pm EST 

Nov 7 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER OF FISCAL 2018.Q4 REVENUE $813.5 MILLION VERSUS I/B/E/S VIEW $806.5 MILLION.Q4 NON-GAAP EARNINGS PER SHARE $0.58.Q4 GAAP EARNINGS PER SHARE $0.18.Q4 EARNINGS PER SHARE VIEW $0.58 -- THOMSON REUTERS I/B/E/S.COMPANY EXPECTS "SOLID" REVENUE AND EPS GROWTH IN FISCAL 2019.SEES FISCAL 2019 REVENUE $3,290 MILLION - $3,335 MILLION.SEES FISCAL 2019 EARNINGS PER SHARE $1.33 - $1.37.SEES FISCAL 2019 ADJUSTED EARNINGS PER SHARE $2.38 - $2.42.SEES Q1 2019 REVENUE $800 MILLION - $815 MILLION.SEES Q1 2019 EARNINGS PER SHARE $0.28 - $0.30.SEES Q1 2019 ADJUSTED EARNINGS PER SHARE $0.55 - $0.57.FY2019 EARNINGS PER SHARE VIEW $2.42, REVENUE VIEW $3.31 BILLION -- THOMSON REUTERS I/B/E/S.Q1 EARNINGS PER SHARE VIEW $0.58, REVENUE VIEW $817.5 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Hologic To Acquire Focal Therapeutics For $125 Million
Wednesday, 26 Sep 2018 04:01pm EDT 

Sept 26 (Reuters) - Hologic Inc ::HOLOGIC TO ACQUIRE FOCAL THERAPEUTICS FOR $125 MILLION, STRENGTHENING BREAST SURGERY FRANCHISE.HOLOGIC TO ACQUIRE FOCAL THERAPEUTICS FOR $125 MILLION, STRENGTHENING BREAST SURGERY FRANCHISE.HOLOGIC INC - ACQUISITION IS ESTIMATED TO BE NEUTRAL TO HOLOGIC'S NON-GAAP EARNINGS PER SHARE IN FISCAL 2019, AND ACCRETIVE THEREAFTER.HOLOGIC INC - TRANSACTION IS ACCRETIVE TO REVENUE GROWTH RATE AND GROSS MARGIN.  Full Article

Hologic Inc Expects EPS In Q4 To Be At Low End Of Prev Gaap And Non-Gaap Guidance Ranges
Wednesday, 12 Sep 2018 05:10pm EDT 

Sept 12 (Reuters) - Hologic Inc ::HOLOGIC INC - EXPECTS CYNOSURE REVENUE IN CURRENT Q4 TO BE ABOUT $15 MILLION LESS THAN PREVIOUSLY FORECAST.HOLOGIC INC - ESTIMATE INCLUDES LOST SALES OF TEMPSURE VITALIA IN Q4.HOLOGIC INC - REAFFIRMING ITS FINANCIAL GUIDANCE PROVIDED ON JULY 31, 2018.HOLOGIC INC - EXPECTS EPS IN FISCAL Q4 TO BE AT LOW END OF PREVIOUS GAAP AND NON-GAAP GUIDANCE RANGES.HOLOGIC INC - "CANNOT YET PREDICT WHEN IT WILL RESUME SELLING TEMPSURE VITALIA".  Full Article

FDA Approves New Innovations On Hologic's 3Dimensions™ Mammography System
Tuesday, 27 Mar 2018 08:06am EDT 

March 27 (Reuters) - Hologic Inc ::FDA APPROVES NEW INNOVATIONS ON HOLOGIC'S 3DIMENSIONS™ MAMMOGRAPHY SYSTEM, THE FASTEST, HIGHEST RESOLUTION BREAST TOMOSYNTHESIS SYSTEM EVER(1).HOLOGIC INC - CLARITY HD HIGH-RESOLUTION 3D IMAGING AND INTELLIGENT 2D IMAGING TECHNOLOGY GOT PMA APPROVAL FROM FDA.  Full Article

Koninklijke Philips And Hologic Announce Global Partnership Agreement
Friday, 2 Mar 2018 03:00am EST 

March 2 (Reuters) - Koninklijke Philips Nv ::PHILIPS AND HOLOGIC ANNOUNCE GLOBAL PARTNERSHIP AGREEMENT TO PROVIDE INTEGRATED IMAGING SOLUTIONS FOR WOMEN'S HEALTH.FINANCIAL DETAILS OF AGREEMENT WERE NOT DISCLOSED.PARTNERSHIP IS A MULTI-YEAR, NON-EXCLUSIVE GLOBAL AGREEMENT.  Full Article

Hologic Reports Q1 GAAP Earnings Per Share $1.45
Thursday, 8 Feb 2018 04:01pm EST 

Feb 8 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL 2018.Q1 NON-GAAP EARNINGS PER SHARE $0.55.Q1 GAAP EARNINGS PER SHARE $1.45.Q1 REVENUE ROSE 7.7 PERCENT TO $791.1 MILLION.REITERATES FULL-YEAR REVENUE GUIDANCE.PERFORMED PRELIMINARY CALCULATIONS AND RECORDED A DISCRETE NET TAX BENEFIT OF $329.2 MILLION IN QUARTER DUE TO TAX CUTS AND JOBS ACT.SEES FY 2018 GAAP EPS $2.36 TO $2.41.SEES 2018 NON-GAAP EPS $2.22 TO $2.27.Q1 EARNINGS PER SHARE VIEW $0.50, REVENUE VIEW $785.9 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $2.20, REVENUE VIEW $3.24 BILLION -- THOMSON REUTERS I/B/E/S.SEES Q2 GAAP EPS $0.27 TO $0.28.SEES Q2 REVENUE $770 MILLION TO $785 MILLION.SEES Q2 GAAP REVENUE $770 MILLION TO $785 MILLION.SEES Q2 NON-GAAP EPS $0.53 TO $0.54.Q2 EARNINGS PER SHARE VIEW $0.53, REVENUE VIEW $790.7 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Hologic Announces Pricing Of Offering Of $1 Bln Of Senior Notes
Tuesday, 16 Jan 2018 07:40pm EST 

Jan 16 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES PRICING OF OFFERING OF $1 BILLION OF SENIOR NOTES.PRICED ‍$600 MILLION AGGREGATE PRINCIPAL AMOUNT OF ADDITIONAL 4.375% SENIOR NOTES DUE 2025 AT AN ISSUE PRICE OF $1,000 PER $1,000​.‍ PRICED $400 MILLION AGGREGATE PRINCIPAL AMOUNT OF 4.625% SENIOR NOTES DUE 2028 AT AN ISSUE PRICE OF $1,000 PER $1,000​.  Full Article

Hologic Announces Offering Of $1 Billion Of Senior Notes
Tuesday, 16 Jan 2018 07:54am EST 

Jan 16 (Reuters) - Hologic Inc ::HOLOGIC ANNOUNCES OFFERING OF $1 BILLION OF SENIOR NOTES.HOLOGIC - LAUNCHED $1 BILLION OF SENIOR NOTES WHICH IS TO BE ALLOCATED BETWEEN ADDITIONAL 4.375% SENIOR NOTES DUE 2025 AND NEW SENIOR NOTES DUE 2028.HOLOGIC SAYS TO USE PROCEEDS OF OFFERING, AVAILABLE CASH TO REDEEM OUTSTANDING $1.0 BILLION 5.25% SENIOR NOTES DUE 2022.  Full Article

Hologic loses bid to dismiss bioMerieux's HIV test patent case

Diagnostic testing company bioMerieux SA can move forward with a lawsuit alleging that HIV testing kits manufactured by rival Hologic Inc infringe two of its patents, a federal judge in Delaware has ruled.